Diagnosis and treatment of acromegaly complications
A Giustina, FF Casanueva, F Cavagnini… - Journal of …, 2003 - Springer
Abstract The Pituitary Society in conjunction with the European Neuroendocrine Association
held a consensus workshop to develop guidelines for diagnosis and treatment of the co …
held a consensus workshop to develop guidelines for diagnosis and treatment of the co …
Acromegaly: update on management and long-term morbidities
L Kasuki, X Antunes, EB Lamback… - Endocrinology and …, 2020 - endo.theclinics.com
Acromegaly - Endocrinology and Metabolism Clinics Skip to Main Content Advertisement
Endocrinology and Metabolism Clinics Log in Register Log in Subscribe Claim Skip menu …
Endocrinology and Metabolism Clinics Log in Register Log in Subscribe Claim Skip menu …
Challenges in the diagnosis and management of acromegaly: a focus on comorbidities
Introduction Acromegaly is a rare, insidious disease resulting from the overproduction of
growth hormone (GH) and insulin-like growth factor 1 (IGF-1), and is associated with a range …
growth hormone (GH) and insulin-like growth factor 1 (IGF-1), and is associated with a range …
Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities
R Pivonello, RS Auriemma, LFS Grasso, C Pivonello… - Pituitary, 2017 - Springer
Acromegaly is associated with an enhanced mortality, with cardiovascular and respiratory
complications representing not only the most frequent comorbidities but also two of the main …
complications representing not only the most frequent comorbidities but also two of the main …
A consensus on the diagnosis and treatment of acromegaly complications
S Melmed, FF Casanueva, A Klibanski, MD Bronstein… - Pituitary, 2013 - Springer
Abstract In March 2011, the Acromegaly Consensus Group met to revise and update the
guidelines on the diagnosis and treatment of acromegaly complications. The meeting was …
guidelines on the diagnosis and treatment of acromegaly complications. The meeting was …
Guidelines for acromegaly management: an update
" Objective: The Acromegaly Consensus Group reconvened in November 2007 to update
guidelines for acromegaly management. Participants: The meeting participants comprised …
guidelines for acromegaly management. Participants: The meeting participants comprised …
Acromegaly pathogenesis and treatment
S Melmed - The Journal of clinical investigation, 2009 - Am Soc Clin Investig
Dysregulated growth hormone (GH) hypersecretion is usually caused by a GH-secreting
pituitary adenoma and leads to acromegaly—a disorder of disproportionate skeletal, tissue …
pituitary adenoma and leads to acromegaly—a disorder of disproportionate skeletal, tissue …
Acromegaly: the disease, its impact on patients, and managing the burden of long-term treatment
DT Adelman, KJP Liebert, LB Nachtigall… - … journal of general …, 2013 - Taylor & Francis
Acromegaly is a rare disease most often caused by the prolonged secretion of excess
growth hormone from a pituitary adenoma. The disease is associated with multiple …
growth hormone from a pituitary adenoma. The disease is associated with multiple …
[引用][C] Clinical review 75: recent advances in pathogenesis, diagnosis, and management of acromegaly
S Melmed, K Ho, A Klibanski, S Reichlin… - The Journal of …, 1995 - academic.oup.com
The CLINICAL consequences of advanced acromegaly are disfigurement, disability, and
shortened life expectancy due to respiratory, metabolic, cardiovascular, and malignant …
shortened life expectancy due to respiratory, metabolic, cardiovascular, and malignant …
Systemic complications of acromegaly: epidemiology, pathogenesis, and management
This review focuses on the systemic complications of acromegaly. Mortality in this disease is
increased mostly because of cardiovascular and respiratory diseases, although currently …
increased mostly because of cardiovascular and respiratory diseases, although currently …